Summary
Cencora, Inc. (formerly AmerisourceBergen Corporation) announced the completion of its acquisition of H.D. Smith Holding Company, the largest independent pharmaceutical wholesaler in the United States, effective January 2, 2018. This significant strategic move was finalized with a cash payment of $815 million, subject to a standard working capital adjustment. The acquisition was previously disclosed in a November 21, 2017, 8-K filing. This transaction is expected to enhance Cencora's market position and distribution capabilities within the U.S. pharmaceutical supply chain. Investors should monitor the integration of H.D. Smith and its impact on Cencora's financial performance, including revenue growth, cost synergies, and overall profitability. The company furnished a news release dated January 3, 2018, detailing the acquisition completion.
Key Highlights
- 1Cencora, Inc. (then AmerisourceBergen) completed the acquisition of H.D. Smith Holding Company on January 2, 2018.
- 2H.D. Smith is the largest independent pharmaceutical wholesaler in the U.S.
- 3The acquisition price was $815 million in cash, with a customary working capital adjustment.
- 4H.D. Smith has become a wholly-owned subsidiary of Cencora.
- 5The transaction was initially announced on November 20, 2017.
- 6The company issued a news release on January 3, 2018, to disclose the completion of the acquisition.